-
Start Preamble
Start Printed Page 44931
End Preamble
Start Supplemental Information
Correction
In rule document 02-15994 beginning on page 42709 in the issue of Tuesday, June 25, 2002, make the following corrections:
1. On page 42709, in the third column, under SUPPLEMENTARY INFORMATION: in the ninth line “COP” should read “CPO”.
2. On the same page, in the same column, under SUPPLEMENTARY INFORMATION: in the second paragraph, in the fourth line, “comment” should read “document”.
3. On the same page, in the same column, under SUPPLEMENTARY INFORMATION: in the third paragraph, in the first line, “commission” should read “Commission”.
End Supplemental Information Start Preamble End Preamble Start Supplemental InformationCorrection
In notice document 02-15736 beginning on page 42259, in the issue of Friday, June 21, 2002 make the following corrections:
On page 42262, the table should read as set forth below:
Examples:
(1) Domestic:
A B C D E F G H I J K L S GSAA GD HHG RXPG8TY43 Q794912349XXXXX 19990612 S12345XX V 19990105 19990312 007 M N O P Q R S T U T U MO00 64131 OK00 71222 10030 0400 056 12500 05500 SMITH-BATTSONXX 103777444 * * * * *End Supplemental Information Start Preamble End Preamble Start Supplemental InformationCorrection
In proposed rule document 02-15358 beginning on page 14642 in the issue of Wednesday, June 19, 2002, make the following corrections:
1. On page 41644, in the second column, in the first paragraph, in the eight and tenth lines from the bottom, “802©” should read “802(c)”.
2. On page 41645, in the first column, in the last paragraph, in the first line, “§312.110©” should read “§312.110(c)”.
3. On page 41646, in the first column, in the last paragraph, in the third, sixth, and 15th lines “802©” should read “802(c)”.
4. On the same page, in the second column, in the first complete paragraph, in the 12th line, “802©” should read “802(c)”.
End Supplemental Information Start Preamble End Preamble Start Supplemental InformationCorrection
In rule document 02-13164 beginning on page 36512 in the issue of Friday, May 24, 2002, make the following correction:
On page 34514, in the first column, correct the signature to read as follows:
Start SignatureAndrew J. Beaulieu,
Acting Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. C2-15994 Filed 7-3-02; 8:45 am]
BILLING CODE 1505-01-D
[FR Doc. C2-15736 Filed 7-3-02; 8:45 am]
BILLING CODE 1505-01-D
[FR Doc. C2-15358 Filed 7-3-02; 8:45 am]
BILLING CODE 1505-01-D
[FR Doc. C2-13164 Filed 7-3-02; 8:45 am]
BILLING CODE 1505-01-D
Document Information
- Published:
- 07/05/2002
- Department:
- Food and Drug Administration
- Entry Type:
- Correction
- Document Number:
- C2-15994
- Pages:
- 44931-44931 (1 pages)
- Docket Numbers:
- Docket No. 00N-1663
- RINs:
- 0910-AA61: Investigational New Drugs: Export Requirements for Unapproved New Drug Products, 3038-AB60
- RIN Links:
- https://www.federalregister.gov/regulations/0910-AA61/investigational-new-drugs-export-requirements-for-unapproved-new-drug-products
- PDF File:
- c2-15994.pdf
- CFR: (1)
- 17 CFR 4